Invention Grant
- Patent Title: Treatment with anti-ErbB2 antibodies
-
Application No.: US16186756Application Date: 2018-11-12
-
Publication No.: US10280228B2Publication Date: 2019-05-07
- Inventor: Sharon A. Baughman , Steven Shak
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Ginger R. Dreger; Samuel Kais
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C12Q1/68 ; C07K16/30 ; A61K31/337 ; C07K16/32 ; A61K45/06 ; A61K38/00 ; A61K39/00
Abstract:
The present invention concerns dosages for treatment of human cancer patients with an anti-Epidermal Growth Factor Receptor (EGFR) antibody.
Public/Granted literature
- US20190071516A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES Public/Granted day:2019-03-07
Information query
